文献速递肝病消化道肿瘤与早癌

空间单细胞分析与邻域分析揭示肝细胞癌中与检查点抑制剂治疗结局相关的免疫架构决定因素

Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma.
PubMed 文献 · Gut · 2025-02-06

该研究对101例肝细胞癌组织进行多重成像质谱流式检测,通过空间单细胞分析在发现与验证队列中解构免疫架构异质性,建立空间免疫分类并测试其对免疫检查点抑制剂治疗的预测价值。识别出三种空间免疫类型(耗竭型、分隔型、富集型),富集型患者无进展生存期显著改善,瘤内异质性患者中一个富集区域的存在决定长期生存。

要点

  • 基于免疫细胞空间互作的无监督邻域检测识别出三种免疫架构,分别以CD8 T细胞、髓系免疫细胞或B细胞与CD4 T细胞为主。
  • 据此定义三种空间免疫类型:耗竭型、分隔型和富集型,反映更高水平的瘤内免疫细胞组织化。
  • 免疫检查点抑制剂治疗下无进展生存期在空间免疫类型间差异显著,富集型患者生存改善。

核心结论

  • 空间免疫网络架构的解构可识别肝细胞癌中具有临床相关性的免疫类型,富集型与免疫检查点抑制剂治疗下无进展生存期改善相关。

研究设计与样本

  • 对101例肝细胞癌组织进行高多重成像质谱流式检测,在发现队列和验证队列中开展深度空间单细胞分析。

主要发现

  • 生物信息学分析在肝细胞癌肿瘤微环境中识别出23种主要免疫、基质、实质和肿瘤细胞类型。
  • 无监督邻域检测基于免疫细胞空间互作识别出三种免疫架构,分别以CD8 T细胞、髓系免疫细胞或B细胞与CD4 T细胞为主。
  • 定义三种空间免疫类型:耗竭型、分隔型和富集型。
  • 免疫检查点抑制剂治疗下无进展生存期在空间免疫类型间差异显著,富集型患者生存改善。
  • 在瘤内异质性患者中,一个富集区域的存在决定长期生存。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The determinants of the response to checkpoint immunotherapy in hepatocellular carcinoma (HCC) remain poorly understood. The organisation of the immune response in the tumour microenvironment (TME) is expected to govern immunotherapy outcomes but spatial immunotypes remain poorly defined. OBJECTIVE: We hypothesised that the deconvolution of spatial immune network architectures could identify clinically relevant immunotypes in HCC. DESIGN: We conducted highly multiplexed imaging mass cytometry on HCC tissues from 101 patients. We performed in-depth spatial single-cell analysis in a discovery and validation cohort to deconvolute the determinants of the heterogeneity of HCC immune architecture and develop a spatial immune classification that was tested for the prediction of immune checkpoint inhibitor (ICI) therapy. RESULTS: Bioinformatic analysis identified 23 major immune, stroma, parenchymal and tumour cell types in the HCC TME. Unsupervised neighbourhood detection based on the spatial interaction of immune cells identified three immune architectures with differing involvement of immune cells and immune checkpoints dominated by either CD8 T-cells, myeloid immune cells or B- and CD4 T-cells. We used these to define three major spatial HCC immunotypes that reflect a higher level of intratumour immune cell organisation: depleted, compartmentalised and enriched. Progression-free survival under ICI therapy differed significantly between the spatial immune types with improved survival of enriched patients. In patients with intratumour heterogeneity, the presence of one enriched area governed long-term survival.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Salié H, Wischer L, D'Alessio A, et al. Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma. Gut. 2025. PMID: 39349005. doi:10.1136/gutjnl-2024-332837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。